Concepedia

Comparable outcome of liver transplantation with Histidine-Tryptophan-Ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial

Alexander Kaltenborn, Jill Gwiasda, Volker Eric Amelung, Christian Krauth, Frank Lehner, Felix Braun, Jürgen Klempnauer, Benedikt Reichert, Harald Schrem

BMC Gastroenterology · 2014 · 24 citations · 17 references

DOIFull text

Open access

References

17

Biliary complications following liver transplantation in the model for end-stage liver disease era: Effect of donor, recipient, and technical factors

Theodore H. Welling, David G. Heidt, Michael J. Englesbe et al. · Liver Transplantation · 2007 · 219 citations · Full text

, , +17

The Evolution of Liver Transplantation During 3 Decades

Vatche G. Agopian, Henrik Petrowsky, Fady M. Kaldas et al. · Annals of Surgery · 2013 · 194 citations

Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation

J. Erhard, R. Länge, R. Scherer et al. · Transplant International · 1994 · 150 citations

Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - limitations of the ‘sickest first’-concept

Tobias J. Weismüller, Panagiotis Fikatas, Jan Schmidt et al. · Transplant International · 2010 · 147 citations

Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

Zoe A. Stewart, Andrew M. Cameron, A.L. Singer et al. · American Journal of Transplantation · 2008 · 128 citations · Full text

, , +15